一个随机双盲,安慰剂控制的人类乳头瘤病毒治疗疫苗PepCan的I/II期临床试验,用于减少头癌复发

相关实验视频

Updated: Feb 7, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Emily Bivens, Omar Atiq, Teresa Evans

medRxiv : the preprint server for health sciences

|February 6, 2026

概括

头癌 (HNC) 疫苗PepCan是安全的,但在一项小型试验中没有显著减少复发. 需要进一步的研究来确认其在预防癌症复发方面的有效性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗学疫苗学疫苗学

背景情况:

头癌 (HNC) 在初始治疗后经常复发.
目前,还没有建立任何干预措施,以防止HNC患者在没有疾病证据的情况下复发.

研究的目的:

评估治疗性人类乳头瘤病毒 (HPV) 疫苗PepCan在减少HNC患者复发率方面的安全性和有效性.

主要方法:

一个随机试验涉及HNC患者没有疾病的证据,比较PepCan (HPV 16 E6与Candin辅助剂) 与安慰剂.
通过不良事件监测安全性,并通过两年内复发率来确定疗效.
分析了免疫反应,包括T细胞活性和细胞因子概况.

主要成果:

一般来说,PepCan是安全的,注射部位反应是最常见的不良事件.
发生了两种剂量限制性毒性 (过敏反应).
在PepCan (45% ITT, 56% PP) 和安慰剂 (80% ITT, 80% PP) 组之间,复发率在统计学上没有差异.
在PepCan组的非复发与增加的T细胞免疫反应对HPV 16 E6和更高的疫苗接种前T辅助型1细胞相关.

结论:

虽然PepCan表现出安全的特征,但剂量限制性毒性是可能的.
该研究表明,PepCan可能不会有效地减少HNC复发,但由于样本规模小,结果是不确定的.
需要进行更大规模,充足的研究来最终确定PepCan的疗效和对HNC治疗模式的潜在影响.

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

相关概念视频

Blind Procedures

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...

Arteries of the Head and Neck

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...

Veins of Head and Neck

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...